Carcinogenic Action of 2′-Chloro-4-Dimethylaminostilbene, in Relation to (A) Possible Effect of Growth Hormone, and (B) Composition of Liver Cytoplasm by Reid, E.
123
CARCINOGENIC ACTION OF 2'-CHLORO-4-DIMETHYLAMINOSTIL-
BENE, IN RELATION TO (A) POSSIBLE EFFECT OF GROWTH
HORMONE, AND (B) COMPOSITION OF LIVER CYTOPLASM
E. REID*
From the Chester Beatty Research Institute, Institute of Cancer Research:
Royal Cancer Hospital, London, S.W.3
Received for publication December 30, 1955
THE possibility that pituitary growth hormone (GH) may influence the action
of carcinogens has been little investigated (see review by Reid, 1954). This
aspect has now been studied, with negative results, in rats which were given 2'-
chloro-4-dimethylaminostilbene by intraperitoneal injection in the expectation
that tumours should arise at diverse sites (cf. Elson, 1952). It was thought that
GH might influence the distribution, if not the incidence of the tumours,
particularly since it has been reported that tumours arise in sites such as the lungs.
(Moon, Simpson, Li and Evans, 1950a) and reproductive organs (Moon, Simpson,
Li and Evans, 1950b) in normal female rats given chronic treatment with GH.
An elevation in the amount of ribonucleic acid (RNA) in liver has been
reported to occur in mice bearing transplanted tumours (Lombardo, Travers and
Cerecedo, 1953; cf. Ceriotti, 1955). It was of interest to ascertain whether the
presence ofprimary tumours, as now induced in rats, affects the amount of RNA
in liver. Accordingly, in part (B) of this study, determinations were made of
the distribution of RNA among the cytoplasmic fractions obtained from liver by
differential centrifugation.
EXPERIMENTAL
The animals were female albino rats of the Institute colony, aged 6 weeks
initially. The rats were fed the " 20 per cent protein diet" described by Elson
(1952), and were kept in groups of 4 or 5. Each group received a daily food
ration, the amount of which was determined by the consumption of whichever
group had least appetite; thus the average food intake per rat was the same for
each group throughout the experiment (usually 12-14 g./rat/day).
At the outset there were 60 rats, 45 of which were given 2'-chloro-
4-dimethylaminostilbene in arachis oil, by intraperitoneal injection (5 doses, each
of 12 mg.), as in the experiments ofElson (1952). Ofthe 45 rats, 25 were treated
with GH as described below, either until the termination of the experiment (1&
rats) or until one week after the last injection of carcinogen (i.e. for 9 weeks; 16
rats); the others were given saline in place of GH. The remaining 15 rats were
given control injections of arachis oil and of saline.
The GH was prepared from cattlepituitaryglands, essentially by the procedure
of Wilhelmi, Fishman and Russell (1948). The hormone was injected
* British Empire Cancer Campaign Research Fellow.subcutaneously in saline solution, containing 1 part in 10,000 of " Merthiolate ",
at a slightly alkaline pH. Injections were given thrice weekly, initially at a
dose level of 1-2 mg./week. With a view to averting the development of a
"refractory state ", as judged by measurements of gain in body-weight, the dose
of GH was doubled after 2 weeks, and again after further periods of 2 weeks, 20
weeks, and 14 weeks (i.e. final dose 19-2 mg./week). Nevertheless, body-weight
measurements made 10 months from the commencement of the experiment,
excluding those rats which had developed tumours, showed that the overall
weight gain for the rats undergoing chronic treatment with GH no longer exceeded
that for the rats in the other groups.
Each rat was killed about 1 month after the first appearance of a tumour, at
which time this tumour usually weighed about 50 g. The presence of any
other superficial tumours was noted at autopsy, and samples taken for histo-
logical examination. The abdomen and thorax were opened, and the pituitary
exposed; any tissue which appeared abnormal was examined histologically.
Cytoplasmic fractions were prepared from liver, and analyzed for RNA
(expressed as phosphorus), by procedures described elsewhere (Reid, 1955, 1956).
The medium was 0-25 M sucrose, and the following fractions were obtained in
addition to the crude " nuclear " fraction (which was discarded): mitochondrial
fraction, including the " fluffy layer ", microsomal fraction, and supernatant
fraction, i.e. non-sedimented material. To minimize the effect of possible day-
to-day variations in environment or technique, the analytical data for each group
ofexperimental rats were not directly averaged, but were compared with those for
control rats killed simultaneously and the differences averaged.
RESULTS
Part A.-As in earlier experiments with other carcinogens and with ad lib-
feeding (Haddow, Scott and Scott, 1937), administration of the carcinogen led to
a partial inhibition of growth. In the first 9 weeks of the experiment the weight
gain in grams for the rats given carcinogen but no GH was 56-5 ± 3 05 (mean ±
standard error), and that for the untreated controls kept on the same food intake
was 66-5 ± 3-32, the difference being significant (P < 5 per cent) by the usual t
test. The weight gain for the rats receiving both carcinogen and GH was 65-0 i
2-53, this value being significantly different (P < 5 per cent) from that for the
rats given carcinogen only.
The data for carcinogen-treated rats are summarized in Table I in relation to
the approximate time of appearance of superficial tumours. Data for the control
rats given no carcinogen are not tabulated; among these rats there developed
only one tumour, a mammary tumour arising after some 450 days. Almost all
the tumours in the rats given carcinogen (with or without GH) arose on the ventral
surface ofthe body, usually near the axilla or groin. These tumours were usually
recognizable histologically as mammary tumours, some undergoing carcinomatous
changes; the stroma showed proliferative changes of varying extent. Some of
these tumours were actually observed to have a high milk content at autopsy.
In a few instances tumours were also found in other sites, as noted in Table I.
It is evident that GH treatment, given either throughout the experiment or in
the initial stage only, had little quantitative or qualitative effect on the carcino-
genic action of 2'-chloro-4-dimethylaminostilbene.
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TABLE I.-Incidence of Tumours
GH treatment.
None
Number of rats.
16, later 13* {
Initial . . . 12, later 11* I-
Throughout
Days between 1st
carcinogen injection
and autopsy of
tumour-bearing rats.
151-290
291-430
431-563
Whole experiment
151-290
291-430
431-563
Whole experiment
151-290
291-430
431-563
Whole experiment
Number of
rats with
tumours.
2
4
7
13
= 100%
0
6
* 4
10
= 90%
1
3
5
9
= 100%
* Reduced number because some rats without tumours died (probably of pneumonia) or were
killed before 360 days had elapsed.
t 2 were non-mammary, viz. a squamous cell carcinoma of the cheek and, in the same rat, an
early hepatoma.
$ 2 were non-mammary, viz. a lung carcinoma (secondary mammary tumour ?) and, in the same
rat, an early chromophobe adenoma of the pituitary.
§ 2 were non-mammary, viz. squamous cell carcinomas ofthe cheek (2 rats).
I 1 was non-mammary, viz. a squamous cell carcinoma of the cheek.
2 were non-mammary, viz. an eye granuloma and, in the same rat, a thigh granuloma.
TABLE II.-Datafor Cytoplasmic Fractions Derivedfrom
Livers of Carcinogen-treated Rats.
Liver-weight as % body-weight
Carcinogen-treated rats: difference
Control rats: from corresponding control rats.*
mean A
value. Without tumour. Tumour-bearing.
2- 79 . +0-19 ± 0-081 + 1-13+ 0-132
(8) (15; P<0-1%)
Mitochondrial . 162
Yields of freeze-dried Microsomal 94
fractions, as mg./
100 g. body-weight
Supernatant . 252
+41 +15-7
(8; P<5%)
. +14 5-9
(8; P<5%)
. +63 ±17-2
(8; P<1%)
+40 ±10-7
(13; P<2-5%)
+25 9-3
(15; P<2-5%)
+68 ± 9-3
(15; P<0-1%)
Mitochondrial . 0-46 . 0-05 + 0-057 - 0-05+ 0-023
(5) (8)
RNAP content of
freeze-dried frac- Microsomal . 0-67 . + 0-04 i 0-032 - 0-03+ 0-043
tions, as mg./100 (5) (8)
mg. dried fraction
Supernatant 0 O28 .-0 005± 0*013 0 i0 030
(5) (8)
* With standard error of mean difference (and number of degrees of freedom); P denotes the
probability that the difference could be due to chance.
Total
number of
tumours.
2
lit
17
30
0
13T
14§
27
1
811
11¶
20
125
1
9Part B.-The administration of GH to normal female rats does not influence
the composition of liver cytoplasm, with respect to the yields of the fractions or
the concentration of RNA in the fractions (Reid, 1955). Since the data now
obtained with the livers from carcinogen-treated rats likewise showed no effect of
GH, no distinction is made in Table II between GH-treated rats and rats given
carcinogen only. Since the values obtained with rats killed early in the experiment
(even after only 60 days) were similar to those obtained with rats killed at a late
stage, all values have been combined for the purpose of the Table.
As is shown in TableII, the livers oftumour-bearing rats were greatly enlarged
in relation to total body-weight (tumours included). Rats which had not yet
developed tumours did not show this enlargement, but these rats, in common with
tumour-bearing rats, gave increased yields of the freeze-dried cytoplasmic frac-
tions. These increases in yield were roughly in proportion to the actual yields
of the fractions in control rats.
TableII further shows that there were no significant changes in the concentra-
tion of RNA (expressed as phosphorus) in the cytoplasmic fractions.
DISCUSSION
Part A.-It is of interest that GH, given in moderate dosage, counteracted the
effect of the carcinogen in partially arresting the natural gain in body weight.
This observation does not, of course, prove that endogenous GH secretion is
inhibited in carcinogen-treated rats, as suggested by Elson, Goulden and Warren
(1945). At least, however, it is clear that the effect of the carcinogen on body-
weight is not due merely to a fall in food consumption. In GH-treated rats kept
on a restricted diet, the gain in body-weight is attributable to a metabolic re-
arrangement, involving conservation of protein and water at the expense of fat
(Greenbaum, 1953 ; Young, 1953). Possibly a converse metabolic re-arrangement
occurs in carcinogen-treated rats. At present, however, there are no data for the
effect of carcinogens on the composition of the body as a whole.
The lack of effect of GH on the carcinogenic action of 2'-chloro-4-dimethyl-
aminostilbene is not incompatible with the finding of Moon, Simpson, Li and
Evans (1950a, 1950b) that female rats (initial age 8 months) given GH, but no
carcinogen, have a high incidence of tumours at an age approaching 2 years. In
their experiments food intake was unrestricted, so that it was possible to maintain.
throughout the experiment, an accelerated growth rate which may itself have
favoured the development of tumours. Experiments recently reported, with
mice bearing a transplanted mammary adenocarcinoma, have shown that the
effect of GH may be complex; the immediate effect was an elevation of tumour
weight relative to body weight, whereas the long-term effect was the converse,
the tumour becoming more refractory to GH than the body as a whole (Smith,
Daane, Li, Shimkin, Lyons, Sparks and Furnas, 1954). If, in the present
experiments, food intake had not been restricted, a comparison of GH-treated
rats with rats given only the carcinogen might have shown a difference which
could, however, have been due merely to stimulation of appetite by GH.
Part B.-The observation of a rise in liver-weight in rats bearing a primary
tumour is in agreement with reports that liver-weight is increased, with no change
in the concentration of protein or other constituents; in rats bearing transplanted
tumours (Stewart and Begg, 1953a, 1953b; Babson, 1954; Sherman and
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Forrest, 1955). The freeze-dried cytoplasmic fractions now isolated showed
increases in yield almost in proportion to the increase in liver-weight. It cannot,
of course, be assumed that no changes occurred in the enzyme content of the
fractions; indeed, it is known that the catabolism of citrate, of which the mito-
chondrial fraction is considered to be the site, is depressed in the livers of tumour-
bearing rats (Sherman and Forrest, 1955). There were, however, no consistent
abnormalities in antigen composition with the fractions now obtained from
tumour-bearing rats (Darcy and Reid, unpublished experiments; cf. Darcy, 1955).
Since an increased yield of the cytoplasmic fractions has likewise been found
in the pre-cancerous state, the effect could be attributed to the carcinogen itself,
conceivably acting directly on the liver. In contrast with the present findings,
the development ofliver tumours in rats fed certain azo-dyes is preceded by a fall
in the yield of the mitochondrial and microsomal fractions (Price, Miller, Miller
and Weber, 1949; Schneider, Hogeboom, Shelton and Striebich, 1953). The
effect of 2'-chloro-4-dimethylaminostilbene on liver cytoplasm may, of course,
be quite unrelated to its carcinogenic action, for which the liver is not a site of
predilection with the diet and the carcinogen now employed (Table I; cf. Elson,
1952).
In the pre-cancerous state there was little rise in liver weight. There was no
gross indication of a fall in the amount of material in the " nuclear " fraction (in
which some unbroken cells are present) to off-set the observed rise in the amount
of cytoplasmic material. It is possible that there was a fall in the water content
of the liver.
The concentration of RNA in the cytoplasmic fractions was not significantly
diminished either before or after the development of tumours. The finding of
increased basophilia in the livers of tumour-bearing animals (Ceriotti, 1955) is
thus compatible with the present findings, which are, however, difficult to compare
with those reported by Lombardo, Travers and Cerecedo (1953). These authors
found anincreased concentration ofRNA inliver, on a dry-weight basis, in tumour-
bearing inice; but there are no data to enable their values to be related to liver
weight or to body weight. The present findings are quite different from those
observed with azo-dyes, which may diminish the amount of RNA in the mito-
chondrial and microsomal fractions (Price et al., 1949; Schneider et al., 1953).
Although it is generally considered that RNA plays some role in protein
synthesis, this may not be the sole function of RNA (cf. Reid and Stevens, 1956),
and it would be quite premature to speculate on the metabolic significance of
changes in the amount of liver RNA in association with cancerous changes in the
liver or elsewhere.
SUMMARY
(A) Female rats given 2'-chloro-4-dimethylaminostilbene by intraperitoneal
injection gained less weight during the treatment than untreated rats kept on the
same food intake. Concomitant treatment with pituitary growth hormone (GH)
restored the weight gain to normal. Neither the incidence nor the topical
distribution of the tumours ultimately obtained was markedly influenced by
GH treatment, given either throughout the experiment or only initially.
(B) Rats bearing tumours induced by 2'-chloro-4-dimethylaminostilbene
showed liver enlargement, together with a rise in the yield ofeach ofthe fractions
isolated from liver cytoplasm by differential centrifugation. A similar rise in
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theyieldofeachfraction, but no liver enlargement, was observed in the carcinogen-
treated rats before tumours had developed. The concentration of ribonucleic
acid in the various liver fractions was within normal limits.
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